Blueberries are picked by hand August 6, 2010 at the Charlotte Berry Farm in Charlotte, Vermont. According to a new study by Harvard University researchers, eating whole fruits helps ward off diabetes, while drinking juice can actually raise the risk of developing the disease. In a study published in the British Medical Journal , nutrition experts report that consumption of certain fruitsespecially blueberriescut peoples risk of type 2 diabetes by as much as 26 percent in a survey of more than 180,000 subjects over two and a half decades. Study participants were asked about their consumption of grapes or raisins, prunes, bananas, cantaloupe, apples or pears, oranges, grapefruit, blueberries, strawberries, and stone fruits (peaches, plums, or apricots). Blueberries had the strongest effect on cutting diabetes risk, followed by grapes and apples, especially when three or more servings a week were eaten. A standard serving of blueberries was half a cup.
For the original version including any supplementary images or video, visit http://news.nationalgeographic.com/news/2013/09/130905-blueberries-fruit-juice-diabetes-nutrition-health-science/
Metabolic menace: The not-so-sweet diabetes
While there are many medicines available, I will enlarge on insulin. Treatment means supplementing deficient insulin. In the yesteryears, insulin extracted from pancreas of cows and pigs was injected in patients. With advances, human insulin (made in labs from human cells) and synthetic analogues are now available.
For the original version including any supplementary images or video, visit http://timesofindia.indiatimes.com/city/mumbai/Metabolic-menace-The-not-so-sweet-diabetes/articleshow/22304209.cms
GSMA mHealth Grand Tour Highlights How mHealth Can Prevent Diabetes
To raise awareness of diabetes and showcase the power of mobile health (mHealth) solutions, The GSMA mHealth Grand Tour, a 13-day cycling challenge from Brussels to Barcelona kicked off today at the Autoworld Museum in Parc Cinquantenaire, Brussels. The mHealth Grand Tour will highlight how mobile technology can support diabetes prevention, diagnosis and treatment by increasing the reach and accessibility of healthcare services, cutting the cost of care and minimizing the impact of the illness on peoples lives, said Michael OHara, chief marketing officer, GSMA. The mHealth Grand Tour is a first-of-its-kind observational study designed by Professor Michael Trenell, NIHR Senior Research Fellow and Director, MoveLab, Newcastle University, into the effects of multi-day endurance exercise on blood glucose levels, using data captured and transmitted wirelessly through a multi-vendor mHealth solution. The study will track the health and cycling performance data of elite and sub-elite athletes with type 1 diabetes, as well as cyclists without diabetes. For the observational study, a Dexcom continuous glucose monitor worn by the riders and sensors on their bike computers transmit statistics over the ANT+ protocol to Sony Mobile handsets, so riders can track their own progress. The sensors also transmit the stats to a HMM module that is part of a complete Orange solution that in turn sends them over mobile broadband to a live website and to the cloud, for later download by the observational study team.
For the original version including any supplementary images or video, visit http://www.hitconsultant.net/2013/09/05/gsma-mhealth-grand-tour-highlights-how-mhealth-can-prevent-diabetes/